Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.
Obesity researchers and companies turn toward helping people maintain losses.
Sales of a groundbreaking new Alzheimer’s disease treatment from Eisai and Biogen are finally accelerating, after a sluggish launch last year. Biogen said Wednesday that…
It is the second known case of H5N1 infection in the U.S.
The first major U.S. health insurers have agreed to start paying for the popular anti-obesity drug Wegovy for certain people on Medicare with heart-related conditions.
The California-based maker of medical devices that treat cardiovascular diseases has a market value of nearly $12 billion.
A new database aims to match rare-disease patients with drugs on pharmacy shelves.
Renaming the lowest-risk prostate cancer would cut down on overly aggressive treatment, some doctors say.
Renaming the lowest-risk prostate cancer would cut down on overly aggressive treatment, some doctors say.
Medical advances are turning fatal illnesses into chronic ones, and some health problems are hitting us earlier and more widely.
Medical advances are turning fatal illnesses into chronic ones, and some health problems are hitting us earlier and more widely.